Soto, J <br/><br/>
Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Oct 2001 
 - E57-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1058-4838 
<br/><br/><label>Standard No.: </label>10.1086/322689  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Antiprotozoal Agents--adverse effects<br/>Colombia<br/>Humans<br/>Leishmaniasis, Cutaneous--drug therapy<br/>Male<br/>Military Personnel<br/>Phosphorylcholine--adverse effects<br/>Treatment Outcome